UPDATED Apr 18, 2024
Less coverage brings about more information asymmetry and more opportunities to buy mispriced stocks. Companies valued at less than US$500M with low PE and PEG.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
603538 | CN¥12.34 | -10.9% | -47.4% | CN¥2.6b | n/a | PE14.7x | E33.2% | 1.3% | ||
603538 | CN¥12.34 | -10.9% | -47.4% | CN¥2.6b | n/a | PE14.7x | E33.2% | 1.3% | ||
PBDA | US$1.01 | -7.6% | -52.3% | US$82.5m | US$11.61 | PE9.9x | E96.5% | n/a | ||
PLX | US$1.13 | -7.4% | -51.5% | US$82.5m | US$13.00 | PE9.9x | E96.5% | n/a | ||
INCR.U | ₪1.53 | -7.8% | -73.7% | ₪260.4m | n/a | PE8.2x | E46.6% | n/a | ||
MDP | CA$1.55 | -0.6% | 8.4% | CA$37.9m | CA$3.21 | PE4.7x | E46.9% | n/a | ||
MEDX.F | CA$1.10 | -4.3% | 3.8% | CA$37.9m | CA$2.28 | PE4.7x | E46.9% | n/a | ||
P731 | CA$1.00 | -2.9% | 1.0% | CA$36.9m | CA$2.07 | PE4.7x | E46.9% | n/a |